Frankfurt - Delayed Quote EUR
Soleno Therapeutics, Inc. (6XC.F)
65.85
+1.80
+(2.81%)
As of 9:59:01 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-69,096
-69,096
-24,940
-20,781
-27,770
Investing Cash Flow
-225,682
-225,682
0
-13
-22
Financing Cash Flow
213,025
213,025
180,019
14,092
-128
End Cash Position
87,928
87,928
169,681
14,602
21,304
Capital Expenditure
-218
-218
--
-13
-22
Issuance of Capital Stock
148,955
148,955
137,857
14,108
0
Issuance of Debt
49,888
49,888
0
0
--
Repayment of Debt
--
--
--
0
-8
Free Cash Flow
-69,314
-69,314
-24,940
-20,794
-27,792
12/31/2021 - 8/28/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
25I.SG ImmuPharma PLC
0.0265
-10.17%
328.SG MeiraGTx Holdings PLC
4.7600
-0.83%
688428.SS InnoCare Pharma Limited
20.56
+0.54%
BSFAF BSF Enterprise Plc
0.0584
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.4060
+5.73%
22Z.SG Zealand Pharma A/S
56.18
-6.30%
688068.SS Beijing Hotgen Biotech Co., Ltd.
109.40
-0.18%
GNFTF Genfit S.A.
3.5400
0.00%
CLAZF Claritas Pharmaceuticals, Inc.
0.0001
0.00%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%